Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease
Clinical trial NCT04369183 · COMPLETED
Trial details
- NCT number
- NCT04369183
- Sponsor
- Istanbul University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-01
- Primary completion
- 2020-08-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.